McMaster Immunology Research Centre, Department of Pathology & Molecular Medicine, Hamilton, Ontario, Canada.
Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Sci Rep. 2017 Aug 25;7(1):9525. doi: 10.1038/s41598-017-09909-4.
Lung resident memory T cells (T) characterized by selective expression of mucosal integrins VLA-1 (α1β1) and CD103 (αβ7) are generated following primary respiratory viral infections. Despite recent progress, the generation of lung T and the role of mucosal integrins following viral vector respiratory mucosal immunization still remains poorly understood. Here by using a replication-defective viral vector tuberculosis vaccine, we show that lung Ag-specific CD8 T cells express both VLA-1 and CD103 following respiratory mucosal immunization. However, VLA-1 and CD103 are acquired in differential tissue sites with the former acquired during T cell priming in the draining lymph nodes and the latter acquired after T cells entered the lung. Once in the lung, Ag-specific CD8 T cells continue to express VLA-1 at high levels through the effector/expansion, contraction, and memory phases of T cell responses. Using a functional VLA-1 blocking mAb, we show that VLA-1 is not required for trafficking of these cells to the lung, but it negatively regulates them in the contraction phase. Furthermore, VLA-1 plays a negligible role in the maintenance of these cells in the lung. Our study provides new information on vaccine-inducible lung T and shall help develop effective viral vector respiratory mucosal tuberculosis vaccination strategies.
肺部驻留记忆 T 细胞(T 细胞)的特征是选择性表达黏膜整合素 VLA-1(α1β1)和 CD103(αβ7),它们是在原发性呼吸道病毒感染后产生的。尽管最近取得了进展,但病毒载体呼吸道黏膜免疫接种后肺部 T 细胞的产生和黏膜整合素的作用仍知之甚少。在这里,我们使用一种复制缺陷型病毒载体结核疫苗,表明呼吸道黏膜免疫接种后,肺部 Ag 特异性 CD8 T 细胞表达 VLA-1 和 CD103。然而,VLA-1 和 CD103 是在不同的组织部位获得的,前者是在引流淋巴结中的 T 细胞初始阶段获得的,后者是在 T 细胞进入肺部后获得的。一旦进入肺部,Ag 特异性 CD8 T 细胞在效应/扩增、收缩和记忆阶段继续高水平表达 VLA-1。使用功能性 VLA-1 阻断 mAb,我们表明 VLA-1 对于这些细胞向肺部的迁移不是必需的,但在收缩阶段它会对其进行负调节。此外,VLA-1 在这些细胞在肺部的维持中作用微不足道。我们的研究提供了关于疫苗诱导的肺部 T 细胞的新信息,这将有助于开发有效的病毒载体呼吸道黏膜结核疫苗接种策略。